Thermo Fisher goes Atmanirbhar, begins COVID-19 diagnostic kits production in India
CoviPath COVID-19 RT-PCR Kit has been approved under MDR 2017 rules for in vitro diagnostic use by the Indian Council of Medical Research and Drug Controller General of India in all authorised laboratories
Joe C Mathew | February 17, 2021 | Updated 00:39 IST
US medical device maker Thermo Fisher Scientific has set up a new state-of-the-art manufacturing facility in Bengaluru to produce COVID-19 testing kits and diagnostic solutions. The made in India, for use in India products will be shipped from today onwards and be competitively priced, a company spokesperson said. Thermo Fisher Scientific Inc. is the world leader in diagnostic technology, with annual revenue exceeding $30 billion.
The CoviPath COVID-19 RT-PCR Kit has been approved under MDR 2017 rules for in vitro diagnostic use by the Indian Council for Medical Research (ICMR) and Drug Control General of India (DCGI) in all authorised laboratories. Testing with the kit can be done on Applied Biosystems real-time PCR instruments with FAM dye, VIC dye, and JUN dye or any RT-PCR platform with three dye channels in molecular biology laboratories approved for testing. Samples are collected from nasopharyngeal swab, nasopharyngeal aspirate and bronchoalveolar lavage (BAL) specimens
Bengaluru (Karnataka) [India], February 16 (ANI/PNN): A new state-of-the-art Thermo Fisher Scientific manufacturing facility in Bengaluru will produce testing kits and diagnostic solutions that are made in India for use in India.
CoviPathCOVID-19 RT-PCR Kit, which contains the assays and controls for Thermo Fisher s gold standard RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in individuals suspected of COVID-19.
The CoviPathCOVID-19 RT-PCR Kit has been approved under MDR 2017 rules for in vitro diagnostic use by the Indian Council for Medical Research (ICMR) and Drug Control General of India(DCGI)
in all authorized laboratories. Testing with the kit can be done on Applied Biosystems real-time PCR instruments with FAM dye, VIC dye, and JUN dye or any RT-PCR platform with 3 dye channels in molecular biology laboratories approved for testing. Samples are collected from the nasopharyngeal swab, nasopharyngeal aspirate and bronchoalveolar lavage (BA
Updated:
February 16, 2021 00:26 IST
In Tamil Nadu, over 35% of healthcare/frontline workers had taken the vaccine, Dr. Radhakrishnan said.
Share Article
AAA
A healthcare worker during the first phase of vaccination in Chennai. File
| Photo Credit:
B. Jothi Ramalingam
In Tamil Nadu, over 35% of healthcare/frontline workers had taken the vaccine, Dr. Radhakrishnan said.
With Tamil Nadu all set to go to the polls in a few months, government officials involved in election work would now be included in the priority group of frontline workers for COVID-19 vaccination.
Health Secretary J. Radhakrishnan on Monday said the officials who were to be deployed for election work would be regarded as frontline workers.